Trypanosoma cruzi is a protozoan parasite that causes Chagas disease, a zoonotic infectious disease considered a leading cause of disability and premature death in the Americas, where an estimate of six to seven million people are currently affected. The epidemiological pattern of Chagas disease changed in the last decades, and an increased number of cases has been reported in non-endemic countries of North America (USA and Canada), Europe, Africa, Middle East, and the Pacific (
1). If untreated, this slow-progressing infection persists for a lifetime, causing severe cardiac disease in one third of the cases. However, most of the affected individuals remain undiagnosed and untreated. Understanding
T. cruzi biology is crucial to find alternative approaches to control this silent disease. This Stercorarian trypanosome develops in the posterior gut of triatomine bugs and is transmitted to the mammalian host through the insect feces via skin wound or body mucosa.
T. cruzi has a complex life cycle involving four major developmental stages that colonize very specific niches within its hosts, transitioning from one stage to another stage in response to environmental changes (reviewed in references
2 and
3). The epimastigote replicates in the triatomine midgut, and upon migration to the insect’s hindgut, it adheres to the rectal epithelium and differentiates into metacyclic trypomastigotes (
4,
5). These forms infect the mammalian host, and after invading a host cell, they differentiate to amastigotes. After several rounds of replication, amastigotes transform into cell-derived trypomastigotes, which are released to the bloodstream and either invade other cells or are taken up by a triatomine. The signal transduction pathways driving differentiation in
T. cruzi life cycle are still poorly understood (
2,
6). 3′,5′-cyclic adenosine monophosphate (cAMP) is a small universal second messenger that relays the information from external stimuli into the intracellular environment, triggering cellular responses such as expression of a specific subset of genes, enzymatic activation, and differentiation. In mammalian cells, the basic molecular components of this signaling pathway are well established, and the expression of these proteins in different subcellular compartments determines spatiotemporal dynamics of cAMP signals (
7,
8). Adenylate cyclases (ACs) catalyze the conversion of ATP to cAMP, while phosphodiesterases (PDEs) degrade cAMP, removing the intracellular signal. Canonical cAMP effectors EPAC (exchange protein directly activated by cyclic AMP), cyclic nucleotide-gated (cNMP-gated) ion channels, and protein kinase A (PKA) are either absent or cAMP unresponsive in
T. brucei (
9). In this parasite, cAMP has been found to mediate social motility (SoMo) and the mechanism to evade the mammalian host innate immune response (
10 - 15). In
T. cruzi, cAMP plays a role in metacyclogenesis (
16 - 22) and osmoregulation (
23 - 26). However, these signal transduction pathways remain largely unexplored in trypanosomes. Trypanosome ACs are transmembrane proteins that dimerize to become catalytically active (
2,
6,
22,
27 - 29). In
T. cruzi, these enzymes comprise a multigenic family of putative receptor-type adenylate cyclases (
22,
29), but their individual localization and function remains unknown. One of them (TczAC) has been found to interact with the paraflagellar rod protein and to become active upon dimerization (
30). In addition, antibodies raised against the catalytic domain of ACs label the flagellum and the flagellar pocket of
T. cruzi metacyclic trypomastigotes (
22). Two possible cAMP effectors have been identified in
T. cruzi, PKA (
31 - 33) and cAMP response proteins (CARPs) (
34). Orthologs of other putative cAMP effectors have not been identified in the genome of
T. cruzi. An
in silico analysis identified several cyclic nucleotide monophosphate-binding proteins in
T. cruzi, and at least one of them was shown to bind cAMP
in vitro (TcCARP1) (
34). CARPs are trypanosome-specific proteins that could play a role in a PKA-independent cAMP signaling pathway (
11,
12,
27,
35,
36). Two recent studies have recognized CARP3 as a multi-adenylate cyclase regulator that plays a role in social motility and chemotaxis in
T. brucei (
11,
36). In this study, we identified three components of the cAMP signaling pathway (TcAC1, TcAC2, and TcCARP3) in two different subcellular compartments of
T. cruzi. Our functional characterization of TcAC1 suggests that this protein interacts with TcCARP3 and synthesizes cAMP in two putative signaling domains: the contractile vacuole complex and the distal flagellar domain (flagellar tip). Our results provide evidence on the role of cAMP in the parasite’s ability to sense environmental cues such as nutrient deprivation, osmotic stress, and cell contact to the vector’s hindgut epithelium, mediating cell adhesion, metacyclogenesis, and response to osmotic stress in
T. cruzi.